GENFUNK by Aurell, Erik et al.
Report ISRN:
T2002:15 SICS-T–2002/15-SE
ISSN: 1100-3154
GENFUNK
by
Erik Aurell, Mats Carlsson, Jan Ekman
& Per Kreuger
16th September 2002
{eaurell,matsc,jan,piak}@sics.se
SICS, Swedish Institute of Computer Science
Box 1263, S-164 29 KISTA, SWEDEN
Abstract
This document summarizes the results obtained by SICS in project GEN-
FUNK (2001). The project was carried out in collaboration with Global
Genomics AB (Stockholm, Sweden). Jointly obtained results will be pre-
sented separately. Main funding was provided by Swedish Research Agency
VINNOVA. Project GENFUNK studied a novel approach of measuring the
global gene expression. In the method, mRNA is extracted from a tissue
sample and transformed into cDNA captured on magnetic beads. This is
then acted on by type IIS restriction endonucleases, which recognize cer-
tain short DNA sequences and cut the DNA close to those sequences. The
resulting fragments are amplified in PCR with selected ligation fragments,
and displayed in capillary electrophoresis. Determining the gene expres-
sion levels from the peak data is combinatorial optimization problem, which
can in principle be solved, to give expression levels of most genes active in
sampled cells, with good accuracy.
Keywords: Global gene expression, combinatorial assignment.
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Document description: This document is structured as follows: The Introduction
(Sect. 1) gives a general background, with an emphasis of the biological problem.
Sect. 2 gives a more mathematical outline, and defines the terms used. Sect. 3
summarizes the experimental errors in the Global Genomics procedure that are
pertinent for the algorithmic approach discussed here. Sect. 4 discusses an as-
signment problem, and Sect. 5 the choice of target functions. Sect. 6 discusses an
integer programming model developed by Mats Carlsson. The implementation of
this model, and tests, will be described elsewhere. Sect. 7 discusses a constraint
programming approach developed by Per Kreuger and Jan Ekman. Sect. 8 briefly
discusses a local search approach.
Document history: An earlier version, dated November 5, 2001, merged sev-
eral documents, including text received from Sten Linnarsson, CTO of Global
Genomics AB, on September 20, 2001. Further document history available from
information in the CVS repository /home/sics/eaurell/CVSROOT.
Other documentation: The ideas and motivations behind Global Genomics’
method are described in their patent [13]. A central technical point is the use
of Type IIS restriction enzymes. The web site of the leading commercial provider,
New England Biolabs, gives a wealth of information on these, and other, en-
zymes [16]. SICS and Global Genomics is preparing a joint paper, intended for
Proc. Nat’l. Acad. Sci. (USA), covering essentially Sect. 6 of this report, and
in vivo and in silico tests [5]. Global Genomics and SICS are also preparing a
second paper, intended for Nature Biotechnology, where the integrated procedure
is compared with high-accuracy individual gene expression measurements (real-
time PCR), and the today leading method for global gene expression measure-
ments (microarrays) [14]. Adam Ameur and Jakub Orzekowski Westholm have
expanded upon the ideas sketched below in Sect. 8. Their results are presented in
their joint MSc thesis [1], and will perhaps be presented elsewhere. Jan Ekman
(SICS) and Peter Lönnerberg (Global Genomics) are in charge of preparing a re-
port on ideas how to optimally choose the restriction enzymes used in the Global
Genomics procedure.
Acknowledgments: We thank VINNOVA for financial support under contract
341-2001-05001. E.A. thanks the Swedish Research Council for support under
grant 621-2001-2704. We thank Lars Rasmusson for initiating this project from
the side of SICS, and the management and staff of Global Genomics for gener-
ously sharing their ideas and technical details with us. We particularly thank Sten
Linnarsson, Peter Lönnerberg and Mats Oldin for their time, for a pleasant and
fruitful collaboration, and for patiently explaining the biological background and
motivation.
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1 Introduction
Defining the complexity that ensues when the relatively modest set of about 30 000
human genes is expressed has been called the next step in the genomic revolu-
tion [11, 26]. Preconditions for this step will be accurate, quick and cheap mea-
surement techniques of what the cell is actually doing, on the levels of the tran-
scriptome (read-outs of genes into mRNA), the proteome (proteins synthesized
from mRNA templates), and the metabolome (complete set of metabolites, in-
cluding proteins and other molecular species). Although progress has been made
on the proteome, the most mature experimental techniques give access to the tran-
scriptome. Even so, there is a clear trade-off between quantitatively precise meth-
ods, such as real-time PCR, which are labor-intensive, and methods well suitable
to global analysis, such as microarrays, which have problems with accuracy and
reproducibility.
In microarrays [23, 22] gene-specific probes are synthesized or deposited on a sur-
face, which is then used to probe an mRNA sample. A major technical improve-
ments was the use of direct oligonucleotide synthesis in situ using a mask-based
light-directed system [7], later commercialized by Affymetrix as the GeneChip.
Generally, microarrays have potential or actual problems of cross-talk, in that a
reaction that goes for one probe may also, to some extent, go for another probe.
Anecdotal evidence suggests substantial inter-array variations of measured mRNA
abundances of the same sample. While these problems are likely to be overcome,
the concomitant cost of using, for instance, quasi-redundant multiple probes for
one gene may be significant. Microarrays finally also have the principal limita-
tions of a closed system, in that they can only measure abundances with probes
that have been chosen beforehand. For these reasons there have been several
attempts to find alternatives to micro array technology, avoiding hybridization.
Known examples in the literature include serial analysis of gene expression (SAGE) [25],
integrated procedure for gene identification (IPGI) [27], introduce-amplified frag-
ment length polymorphism (iAFLP) [10], GeneCalling [19], massively parallel
signature sequencing (MPSS) [3], and total gene expression analysis (TOGA) [24].
There have also been attempts to quickly and accurately measure gene expres-
sion levels partially, a procedure known as gene expression profiling. Although
this does not provide information about individual gene expression levels, the re-
sulting profiles may nevertheless be highly specific to a given cellular state. A
benchmark method has been differential display [12], where a cDNA population
is separated by size on an electrophoresis gel. Brenner and Livak [4] used Type
IIS restriction endonucleases to generate 5’ overhangs of an unknown sequence,
tagged the ends with fluorescent dyes, and separated these segements by length
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on a polyacrylamide gel. Kato et al. [9] first divided a sample after cleavage by
the enzyme into subpopulations, which were then separately amplified by PCR.
This general approach using the special properties of Type IIS enzymes was sub-
sequently taken up by several groups [21, 17, 15]. It is not directly suitable for
direct gene expression analysis, since the information obtained usually is not suf-
ficient to determine individual gene expression levels.
A recent proposal to turn Kato’s method into a true global gene expression analy-
sis tool is presented in [20], where an iterative procedure is used. The fragments
after action by one enzyme and after ligation with an adapter, are then treated with
a second restriction enzyme, the process repeated three times. In this set-up two
base pairs are exposed at a time, giving six base pairs of information. The in-
tended use of the method is however primarily genome indexing, not quantitative
measurements of gene expression.
1.1 Statement of the problem
The key idea in the Global Genomics setup is to extend the methods of Brenner-
Livak and Kato by dividing up a cDNA population into two or more subpopula-
tions, and then use different restriction enzymes of the same type on each sub-
population. The technical steps in this procedure have not been fully published,
except for a recently granted patent [13]. Nevertheless, it is quite clear and very
likely that one can thus get much more information on the global gene expression
levels, than by using only one restriction enzyme. It is also clear that the infor-
mation is not directly available, but must be deduced from comparisons of the
profiles from the respective restriction enzymes.
The goal of GENFUNK was to state precisely the above sketched combinato-
rial problem, and to develop methods to solve it. This document will center on
one of the experimental set-ups used by Global Genomics, where three restric-
tion enzymes are used. As will be described elsewhere [5], this allows for the
determination of most expressed genes in mouse. In silico and laboratory experi-
ments [14] further indicate that the method is quantitatively at least as accurate as
microarrays, while still being an open system, capable of detecting any mRNA in
the sample.
2 Mathematical modeling and definitions
Type IIS restriction enzymes, or interrupted palindrome restriction endonucleases,
are proteins that recognize specific DNA base pair sequences, and cuts the DNA
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Figure 2.1: Bipartite graph illustrating the assignment problem of genes to peaks
(or peaks to genes). The concepts genes, fragments and peaks are defined in the
main text.
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some distance away from the recognition site. The two strands are cut with a
small offset, so the action leaves a DNA fragment with an overhang. The prime
reference source for these enzymes is the New England Biolab web site [16].
For the present work one should preferentially choose enzymes with recognition
sequences about five base pairs long, and that leave a four base pair overhang [13].
It is useful to represent the information of the identity of the recognition sequence
as enzyme, or, more generally, as a restriction group. Global Genomics uses lig-
ation fragments that on one side have a four base pair overhang, and primers in
the PCR that on the other side have one of the three letters (G,T,C), followed by a
poly-A string. That gives  
	 possibilities. Each of these is referred to by
Global Genomics as a frame. It might also be useful to have a concept of all the
discrete information we have on fragments, frames and enzymes, e.g. a frameset.
The setup considered here would hence have  	  framesets. Each
of these in fact labels one experiment, characterized by which restriction enzyme
was used, which ligation fragments, and which primers in the PCR. Hence, for a
particular species of mRNA to be likely to be observed, it should be present in at
least about 2500 copies, so that it is present in every experiment, in particular in
its own frameset. In practice, this means that the Global Genomics method can
either measure highly expressed genes from one cell, or weakly expressed genes
from a sample containing many cells. It is not a global gene measurement tool on
the individual cell level.
A significant complication is the fact that many poly-adenylation sites are not
precisely known. It is therefore convenient to define a head-frame as the four
letters overhang, and a sub-frame as the single letter before the poly-adenylation
sequence. The frame is the combination of the head-frame and the sub-frame.
Definition 2.1 a gene is  ID,s,stop,pal  where ID is a unique identifier, s is a
string of nucleotides, stop is a stop position and pal is a pointer to a list of al-
ternative poly-adenylation sites. Such a list contains items  ID,pos,q  , where ID
is a unique identifier, pos is the position of the poly-adenylation site, and q is a
quality indicator. We will later consider q indicators of the type of the uncertainty
in pos.
Definition 2.2 a fragment is  enzyme,frame,length  This represents a string of
integer length length, where we only know the information that it is produced by
enzyme, and occurs in frame.
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Definition 2.3 a peak is  ID,enzyme,frame,length,Area  where ID is an identi-
fier provided with the processed experimental data.
Definition 2.4 a dark peak is  dark,enzyme,frame,length,any  . This models a
peak which was not observed because of technological limitations, e.g. machine
failure, or because length too long or too short. It is not supposed to have been
listed in the experimental data, but to have identifier dark. It can have any area.
Definition 2.5 a zero peak is  zero, enzyme,frame,length,bg  . This models a
peak which was not observed because its area was below the detection limit. It is
not supposed to have been listed in the experimental data, but to have identifier
zero. Its area must be less than bg (background).
Description: There is a link from a gene to a peak if, for a given poly-adenylation
site in   , i) there is a recognition sequence in  for the 
	 within about  
base pairs upstream from   , ii) the overhang left by the restriction enzyme, is
the same as in the head-frame of the peak, iii) there is a letter close to   , up to
the accuracy specified by  , that matches the sub-frame of the peak, iv) the dis-
tance from the recognition sequence closest   is close to the 
 of the peak.
The problem is illustrated by the bipartite graph of Fig. 2.
As will be discussed in the next section, readings of the same gene with differ-
ent poly-adenylation sites, are in fact quite analogous, to the Global Genomics
algorithm, to separate genes. It is therefore convenient to introduce two more de-
rived concepts:
Definition 2.6 a t-gene, for transcribed or terminated gene, is  ID,s,pos,Min,Max 
where ID is a unique identifier, s is a string of nucleotides, pos is the most likely
position of the poly-adenylation site, Min is furthermost possible position of the
poly-adenylation site in the 5’ direction, and and Max the furthermost possible
position of the poly-adenylation site in the 3’ direction. A t-gene is formed from
the information in one gene, and in one entry in its list of poly-adenylation sites.
If there is no information in the quality indicator q on two hard bounds Min and
Max, it can not form a t-gene.
Definition 2.7 A u-gene, for unambiguous gene, is a tuple  ID,s,pos  where pos
is the fixed position of the poly-A site, and the other fields are the same as in a
t-gene. Hence, the sub-frame of a u-gene is uniquely determined as s ff  flfiffi .
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3 Two sources of uncertainty
The bipartite graph encodes two sources of uncertainty.
3.1 Genes-Fragments uncertainty
The genomic information linking genes and fragments may be incomplete. One
possibility is that the set of genes in itself is incorrect or incomplete, for (at least)
the following reasons:
1. some genes may not be present in the data base at all;
2. there are alternative splicings of the same gene, and not all are in the data
base;
3. there are alternative poly-A sites, and not all are in the data base;
4. for a given end, the sequence in the data base may not be complete all the
way to the end
Two readings of the same gene, with the same poly-A site, but with different
splicings, will produce the same 3’ ends of mRNA. They can produce the same
fragments, if the closest cleavage site by the restriction enzyme is where the two
mRNA agree. They can also produce different fragments, if there is no cleavage
site over the stretch where they agree, counting from the 3’ end. These two strings
of DNA (of different length) will however always agree at their 3’ ends.
Two readings of the same gene, with the same splicing, but with different poly-A
sites, will not produce the same 3’ ends of mRNA. They will hence produce differ-
ent fragments. They can produce strings of DNA that partially agree, over some
of their length, counting from the ligation end, if there is no cleavage site between
the two poly-A sites. If there is a cleavage site between the two poly-A sites, they
will produce strings of DNA that typically do not agree at all. A gene, the true
end which is uncertain, is similar in effect to an unknown alternative poly-A site.
A second possibility is sequencing errors, If those errors are at the bases speci-
fying a frame, it would mean that a gene would consistently show up in the wrong
frame. Alternatively, there are single nucleotide polymorphisms (SNPs), and a
sample under consideration might come from an individual with another geno-
type than in the genomic data base. Celera quotes e.g. an average rate of SNP
in the human of one per 1500 base pairs. There are ten base pairs in the frame
and in the recognition sequence of the enzyme. If we assume      to be an
error rate of a genomic sequence, the chance that all of ten base pairs are right is
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 
 fi 




	
. This rate is of course highly dependent on the accuracy of
the genomic sequence, and on the rate of SNPs.
A third possibility is insufficient specificity of the ligation reaction. Ideally, two
DNA sequences with complementary overhangs, say 			 and  			 ,
should combine together, but 			 should not combine with any other. In
fact, the strands are held together by three hydrogen bonds between  and  ,
and two hydrogen bonds between  and  . There is hence some affinity also be-
tween, say, 			 and 			 . One would therefore have to expect some
cross-reaction. Global Genomics has data on these cross-reactions, and methods
to circumvent the problem (information not public).
3.2 Fragments-Peaks uncertainty
The second source of uncertainty is that of experimental errors, in the Global
Genomics setup, of the determination of 
 and ff   of a peak, and in the
comparison with fragments. We can assume that ff   is reproducible up to at
least a factor two. True DNA string length is an integer, while the observed 

is approximately given with one decimal position 1.
Most of the scatter in 
 , of peaks, is in fact systematic, not random. One
effect is that of translation from observational data to processed data, which is
done with size markers. The passage time of a stretch of DNA through a capil-
lary has a non-linear dependence on length. The mapping from passage time to
length is performed by interpolation between the known size markers. There is a
(length-dependent) error of this map, since there are only a finite number of size
markers. Ideally, this should be corrected for.
Secondly, the mapping depends somewhat on the actual sequence. DNA may
have a tendency to curl up, which varies with the sequence. That will effectively
make pieces of DNA of the same length travel at different speeds in the capil-
lary. This error may, as a first approximation, be modeled as a random spread.
Nevertheless, it is not really random, because if one knows the letters in the DNA
piece in question, and measures the passage of this sequence directly through the
sequencing machine, one can determine the actual passage time. One can there-
fore envision that in a future version of this work, these length corrections will be
known, and can be included as corrections in a data base of fragments.
1Resolution of the sequencing machine is about 11 data points per base, run-to-run variability
specs are 15 % of one base.
VINNOVA project 341-2001-05001 (GENFUNK), September 16, 2002 9
4 Assignment
The actual experimental data from a tissue sample is a collection of peaks. Every
peak can be the observation of fragments of one or several genes. The bipartite
graph of Fig. 2 expresses all possible such observations; if a peak   can be an
observation of a gene  there is a link     . Let the set of links be denoted


 	
 



 
fffiffifl 
! (4.1)
It is convenient to consider more restricted link sets that go between t-genes and
peaks:
#"
$
 	% 

%#

t-Genes  & ffffifl  ! (4.2)
The difference between (4.1) and (4.2) is that a link in  only requires there is a
suitable entry in the list of poly-adenylation sites, but does not define which one.
We recall (in this context) the definition of the start and the end of a link:
'
 (

 	
 
 

*)
     +(
 
 
,  (
 
  (4.3)
We can therefore consider much information included in  (and in  " ):

	   (
 

	   
,  (
 

  (
 

    
,  (
 
-
   +(
 
-
    
,  (
 
(4.4)
For (.

"
we have further information on which poly-adenylation site is con-
sidered. Enzyme 
	   (  cleaves the string  in t-gene % at a well-defined site,
and leaves a fragment which agrees in frame with
-
   +(

. Its length is close to

  (

. We define the predicted length of link ( to be the length of this fragment.
Definition 4.1 Definition: an assignment is a subset / of  " such that for each
t-gene  , either there are no links in / or there is a link from  to one distinct
peak per enzyme. The sub-frames of these peaks must be identical.
An assignment can be considered the graph of a function /    
	  :
/
)

   
	
10
 2 

 or /     
 
  for    
   
#" (4.5)
There may be additional acceptability conditions on assignments. These can be
of the type that only some links from a given gene can be assigned together. They
can also be of the type that the links that can be assigned from two genes vary
together, e.g. that they have a common offset in length.
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We can also extend the concept of assignment, to express that perhaps some genes
are only expressed with a given poly-adenylation site in a given sample, or cor-
relations between these expression level. Different poly-A sites of the same gene
could then not be independently assigned to peaks. Similarly, one could also ex-
press that some genes would only appear with a given splicing in a given sample,
or correlations between these expression levels.
5 Optimization
The goal is to determine gene expression levels. We introduce real non-negative
variables  


expression level of t-gene  (5.1)
Given an assignment, we can then compute predicted peak areas:
 

 


	


 ff
 
 (5.2)
The predicted peak areas are functions of the assignment / and the set of gene
expression levels 
 

 . Given an element in an assignment, we also have from
above its predicted length fi   (  .
We then have two kinds of errors. We can compare
 
 with the measured peak
areas, and fi  with the measured peak lengths.
5.1 A Bayesian detour
We will now make a short detour on target functions. Generally, one would often
introduce some function fl  
 

 ff  

ffifi





to minimize. What does this
mean? How to choose the functional form of fl ?
In Bayesian statistics this is framed as the following problem:
1. Let the DATA be the observed peak areas and peak lengths.
2. Let the MODEL be the assignment / and the t-gene expression levels
 

.
3. The measured lengths and areas may be considered realizations of random
variables, where the distributions of the random variables encode the var-
ious error sources. These probabilities hence depend parametrically on /
and the
 

’s, and can be written Prob    ff     

  / 
 


. More
compactly, these conditional probabilities are Prob   DATA  MODEL  .
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4. We seek to find the most likely model given the data, i.e. to maximize
Prob   MODEL  DATA  . By Bayes’ rule:
Prob   MODEL  DATA   Prob   DATA  MODEL

Prob   MODEL 
Prob   DATA  (5.3)
The denominator can be fixed by a normalization condition. The uncondi-
tional probability Prob   MODEL  , Bayes’ prior, is undetermined.
Different choices of Bayes’ prior defines different best ways to solve the problem,
given the knowledge, or belief, about the a priori likelihood of a given model,
expressed by the prior. In each case, however, maximizing the probability in (5.3)
is clearly equivalent to minimizing a target function
fl

fi  Prob   DATA  MODEL  fi  Prob   MODEL  (5.4)
Every assumed target function can be given an interpretation in terms of assumed
probability density functions, and vice versa. If there is no good reason to prefer
one a priori distribution to another, or if the a priori distribution is indeed uni-
form over all models, then one will seek to just directly minimize the maximum
likelihood function:
fl

	

fi  Prob   DATA  MODEL  (5.5)
The discussion of the rest of this section will be framed in the maximum likelihood
language. Let us however remark that the a priori probabilities are most likely
not uniform in the problem at hand. Indeed, it should be possible to determine
reasonable a priori distribution by analysis of the data. The simplest ansatz is to
take all gene expression levels a priori independent, but with a given distribution
   
 
"

. The full target function would then be
fl

fl

	
fi

t-genes
    
 
"
 (5.6)
Interestingly, we have then a compatibility condition, or a fixed point conditions;
namely that the expression levels actually found from minimizing (5.6) should
again be distributed as    
 
"

. With hundreds or thousands of expressed genes in
a given sample this condition could be quite stringent. This point deserves further
investigation.
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5.2 All errors independent
Let us now consider just the maximum likelihood approach, and let first all mea-
surement errors be independent random variables. Then, with some   and  ,
Prob   ff    
   / 
 
  
t-genes

enzymes


	
	  




peaks


 

  


(5.7)
and the target function is
fl
 
t-genes

enzymes
    fi

 
 

 
peaks
  
 

 ff  

 (5.8)
One example is a quadratic target function for lengths
fl


t-genes

enzymes 

  fi

fi 



 (5.9)
which is equivalent to assuming a Gaussian error distribution of lengths. Another
example is an absolute value target function
fl

 
t-genes

enzymes


 fi

fi 


 (5.10)
which is equivalent to assuming an exponential error distribution of lengths.
The peak areas are the outcomes of a multiplicative process (the PCR). Such pro-
cesses often give rise to log-normal distributions. We may therefore also list a
log-normal target function for areas
fl 


peaks


 
 

ff  
fiff

(5.11)
Hard bounds on the length differences should be taken care of in the definition
of

. Hard bounds on differences in expression levels may be taken care of by
modifying the target function on areas.
5.3 Errors from one gene correlated
Proceeding further with the maximum likelihood method, one can also motivate
slightly more complicated target functions. Suppose that the errors in length of the
fragments produced from one gene with different enzymes are not independent.
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That would be the case, for instance, if these fragments share DNA that is curled
up, and travels faster in the capillary. With three enzymes, giving rise to peaks
 

    
 for a given gene, one would then have
fl
 
t-genes
	
  fi


 
 
 

			

 


 ff  


			  (5.12)
This formulation is particularly straight-forward for quadratic target functions.
Let
fi
0

( be the vector of errors in length, with different enzymes, and   a square
matrix, then
fl


 
t-genes


fi
0

(



fi
0

( (5.13)
This corresponds to a Gaussian probability distribution, where the mean of peak
length in enzyme  is fi  , and the peak-peak length correlation is
   
 

fi fi


  
 

fi fi




 




ff (5.14)
The matrix   is hence the inverse of the correlation matrix.
6 A mixed-integer programming approach
In this section, we will develop a mixed-integer programming (MIP) model ex-
pressing the optimization problem. The model is closely related to the bipartite
graph view; see Fig. 2. We now introduce the bipartite graph flfi where the nodes
are u-genes and peaks. ffifi is computed from  " as follows:
1. Expand each t-gene (and its incident links) into multiple u-genes, one for
each possible poly-A site.
2. Remove all links     where ! fi
-
   " 
$#
% fi
-
   2 

.
3. Remove every u-gene (and its incident links) that does not have a link to
one distinct peak per enzyme.
4. Remove all unconnected nodes.
The goal of the MIP model is to compute an assignment /'& flfi and gene
expression levels with minimal total cost; see below. In a first approximation, we
use the measured peak areas as an upper bound on gene expression, and the peak
area error is simply the total unaccounted for peak area. The mismatch in length
between a u-gene and a peak gives the penalty of  "     / :
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 
  

)
UGenes  Peaks 0 ff   (6.1)
For convenience, we define the utility of  "     / as  fi    " 
   The key
idea of the MIP model is to capture the search space by decision (0-1) variables



 , one per link     
 fi
.




 iff  contributes to peak   . We also
need to introduce an expression variable
 

 for every u-gene, and an ancillary
variable
 



 for every link. The model decomposes into independent subprob-
lems, one per connected component of ffifi .
6.1 Determinacy
A subproblem may easily be underdetermined, i.e. admit many optimal solutions
that vary only in the expression levels of some groups of u-genes, reflecting a lack
of data to resolve ambiguities. Rather than reporting an arbitrarily chosen solu-
tion, we would like to reflect the ambiguous evidence in the solutions reported.
To this end, we define the equivalence relation:



 

	


'
 

Peaks  )  " 

 



fi
 

 



fi (6.2)
and replace in the model each u-gene by the equivalence class to which it belongs,
solve the MIP, and then infer bounds on the original expression variables from the
solution found. In other words, we compute a reduced graph:


fi
$
 

 
 



 
 Classes    Peaks ! (6.3)
where each class

  is an equivalence class spawned by  , compute an assign-
ment

/ &

 fi
and class expression levels with minimal total cost, and finally map
those levels back to the original expression variables.
6.2 Variables
All variables are non-negative. Decision variables can take two possible values
only, 0 and 1.
 A decision variable  
  for each link        fi such that      iff
 

 

 / .
 An expression variable
 

 for each class.
 An expression variable
 

fi


 for each decision variable, the value of which
is either 0 or equal to
 


.
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 A slack variable    for each peak, denoting the part of it that is not assigned
to any class.
6.3 Objective function
Within the MIP model, we can capture three relevant, linear criteria on a good
solution: (i) maximal coverage, (ii) maximal expression, (iii) suppression of false
positives. Specifically, we maximize a weighted sum fl  +/  of the following three
terms wrt. the assignment / : (i) negative total relative slack; (ii) total relative
expression level weighted by utility; (iii) negative total penalty:
fl  

/
 
fi



 

 ff 
 


















  

	



 

fi








 
 

  
 




(6.4)
where    

 
 




 
  

. The coefficients 



 and   are subject to
tuning.
6.4 Constraints
Valid assignments. The first type of constraints specify valid assignments. Ev-
ery class

 can contribute to at most     peaks per enzyme, where    denotes
the cardinality (number of elements) of  . Let  denote a very large constant.
'

ff
)


  
 
 	flfi



ffi


   (6.5)
'

 
)
 



 ffi





 (6.6)
No peak overcoverage. The second type of constraints state that no peak should
be overcovered:
'
 
)



 





 


ff      
 (6.7)
Consistent expression levels. The third type of constraints is a consistency rela-
tion between the expression levels of each class, and the ancillary variables
 




for each decision variable:
'

ff
)
 


 

  
 
 	flfi
 



 (6.8)
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Redundant constraints. Introducing a decision variable    for each class, the
following implied constraints can be added, subsuming constraint 6.5. It is unclear
whether this would bring any computational benefit.
' 
  
)


  
 
ff	flfi






 (6.9)
' 
 
)
 


ffi



 (6.10)
6.5 Detecting u-gene and gene expression bounds
For each subproblem and each equivalence class  it contains, the MIP solver
provides a) the total expression,
 


, b) the set of peaks, ff      , that   is as-
signed to c) for each  & ff     
 

ffi

.
In addition, we know the individual u-genes making up  . Let       and
let ff fi  


 denote     ff      
	   2      . We need an auxiliary array
fl
fi
ff   
ffi

ffi

, where:
 


fl
fi
ff  +
 



 




  
ff
fi
 




fl
fi
ff 
ffi
  
ffi
fl
fi
ff


(6.11)
Lower and upper bounds for
 


  

  are obtained using rule 6.12, which is
valid for any enzyme  :
fl
fi
ff 
ffi
 


ffi
fl
fi
ff

 (6.12)
Also, for each gene  , we know the number        of its u-genes that are
included in  . Let
 


 denote the contribution of the class to the expression of
 . Lower and upper bounds for
 


 where     	



 
are obtained using
rule 6.13, which is valid for any enzyme  . Note that these bounds are much
sharper than those obtained by rule 6.12.











	

fl
fi
ff  
ffi
 



ffi



	












fl
fi
ff   (6.13)
Finally, to obtain lower and upper bounds for
 
 , the expression of each gene  ,
we simply compute the sum of the contributions:



  
 
 




ffi
 

ffi



	
 
 



 (6.14)
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6.6 Final remarks
Further constraints on valid assignments can be readily expressed as constraints
on the



 variables.
Many MIP solvers handle so called SOS Type 1 constraints such as con-
straint (6.5) specially. CPLEX, for example, uses special branching strategies
for such sets of variables, and lets the user provide weight information to guide
the search. The weight for


 could e.g. be chosen as        

.
7 A constraint programming approach
Constraint programming (CP) is a general technique for declarative description
and effective solving of large combinatorial problems, with particular applica-
tions to planning and scheduling [2, 8].
The idea of constraint programming is that the user solves problems by stating
constraints (conditions, properties) which must be satisfied by the solution. A
computation engine then executes a search algorithm to find a solution. A good
general constraint solver, e.g. [6], allows for both the user explicitly specifying
the search procedures, and for these being chosen by the solver.
Constraint programming can from one point of view be seen as a user interface to
vanilla-flavor satisfiability and optimization problems. The capability of a solver
hence depends both on the quality of the translation of the constraints (provided by
the user) into a search/optimization problem, and on the power of the algorithms
the solver then employs. The following discussion will be geared to a formula-
tion where the search algorithms are efficient on linear constraints. It therefore
assumes an underlying computational efficiency comparable to the mixed integer
programming approach of Sect. 6. One advantage of constraint programming is
that the formulation is closer to the original problem, and frees the user from the
obligation of casting the same in a format suitable to the search/optimization pro-
cedure. This aspect will be evident in the following description. We note that
a partial implementation has been carried out in the project, but not a full im-
plementation that would allow comparison with the mixed integer programming
approach of Sect. 6.
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7.1 Notations used
The predicted lengths of all the % -genes under the enzymes can be represented as
a

   matrix
fi

fi

  
fi 

.
.
.
.
.
.
.
.
.
fi


  
fi 

Here  is the number of % -genes,   is three in the standard present setup, and each
element fi ff represents the expected length of the fragment of the  ’th gene, from
the 3’ end to the closest recognition sequence in the  ’th RESTRICTION GROUP2 .
The predicted head frame of any % -gene is the overhang left by an enzyme that
cleaves a given sequence at the recognition site closest to    . It is convenient to
define this as a function:
Definition 7.1 Let  be a function from a % -gene  and an enzyme  to the initial
sequence of the fragment produced from  by  . Then         is the predicted
head frame of % -gene  under enzyme  .
Given a value of an offset we can also compute the predicted sub-frame of a
% -gene. This simply means that if the % -gene would end at position  , which lies
within  of    , then the predicted sub-frame is the letter at  . It is also convenient
to give this as a function, viz.
Definition 7.2 Let  be a function from a % -gene  and a (positive or negative)
offset  from the expected length given by fi ff to a sub-frame  such that if the
actual polyadenylation site would give a fragment of length of fi ff   in restriction
group

, then the expression of % -gene  for that restriction group will occur in sub-
frame    	  (of head-frame        ).
Definition 7.3 Let the RESULT OF AN EXPERIMENT be represented by a finite list
of peak parameters
ff  ff


			

ff

sorted by ascending peak position and where the values of each parameter is
referred to as follows:
Let 
 represent the base pair resolution of the experimental equipment, which
can currently be rounded to   steps per base pair, and let      (  denote the
observed position of an observed peak given in units of 
 :th of a base pair,




 (

the observed area in arbitrary units and let furthermore      +( 
denote the restriction group,      +(  the head-frame and      +(  sub-frame
2In the standard current setup, the  ’th out of  restriction endonucleases.
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of each peak ff  3. Since ff is sorted by peak position, we know that the following
condition holds
'

(  
 
(   
 
ffi
  +(
  (7.1)
7.2 Matchings
The central problem is that several % -genes may contribute to a particular peak.
With the simplifying conjecture that a % -gene can contribute to at most one frag-
ment length in each restriction group, also made elsewhere in this report, we can
represent a matching between % -gene expressions and observed peaks as an as-
signment of peak indexes to % -genes. Because of the uncertainty of the exact
polyadenylation site, we need to handle regular offsets occurring in all restriction
groups.
Definition 7.4 Let a MATCHING be represented by an assignment for each % -gene
 of a (discrete) offset variable 
 and of   (discrete) peak variables  


			
 

such that  ff   if the % -gene does not contribute to any peak in a particular
restriction group  and  ff  ( for some   ( ffi   otherwise4.
We require any matching to fulfill for each % -gene  and restriction group  the
following conditions:
'
 
ffi
 
'
 

ffi
 

  ff
# 
    ff
   (7.2)
In other words, any assigned peak occurs in the correct restriction group. The peak
also has to occur in the correct head-frame and for a given offset   the correct
sub-frame, i.e.:
'
 
ffi
 
'
 

ffi
 

  ff
# 
    ff
 
   
   (7.3)
and
'
 
ffi
 
'
 

ffi
 

 	 ff
# 
    ff
 
   	 
  (7.4)
Let each variable 
 have initial domain constrained by
'
 
ffi
 
 
 
ffi
 
ffi

 (7.5)
3Note that  and  correspond to the 	 and fiffffifl  function of Sect. 4 and that the
 "!#
$ function of that section is here split into the two functions % and & .
4The notion of matching defined here is very close to that of Sect. 4. We have here one vari-
able ')(+* for each  -gene , and restriction group  . Assigning a value  to one of these variables
corresponds exactly to letting the value of the expression -/.0,21 3 be  .
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where 
  and   impose hard limits on the offset from the expected polyadeny-
lation site for a given % -gene  . To capture the fact that the expression of a % -
gene cannot occur in one restriction group and not in another (unless the expected
fragment length for that group is  ) we enforce the following condition on the
matching variables for each % -gene  .
'
 
ffi
 
  

 	 ff
 
fi  
#  
    
 
'
 

ffi
 

  ff
     (7.6)
7.3 Matching errors and penalty
The 
 variable captures the uncertainty in the exact position of the polyadenyla-
tion site while the possible assignments for the  ff variables should depend on the
position   of each candidate peak ( . We will define an error variable, which we
will use to enforce further necessary conditions on the matching and a matching
penalty.
Definition 7.5 Let the MISMATCH ERROR   ff of a particular % -gene  in a re-
striction group  be defined as


 


    ff
 

 fi ff


   fi    ff

ffi%
	

	
 
 (7.7)
Since   ff encode the absolute offset from the expected fragment length we
can use it to constrain the matching variables as follows. Let each  ff have an
initial domain   			   and constrain the  ff and   variables by enforcing for
each % -gene  and restriction group  the following condition

 ff
ffi


ff
ffi 
ff (7.8)
where 
 ff and  ff are parameters encoding the maximum acceptable absolute er-
ror in detected fragment length in an experiment for % -gene  in restriction group  .
Motivated by these observations we will enforce limits on the discrepancies be-
tween the errors in the restriction groups for any given % -gene  : For each % -gene
 and any two restriction groups  and  such that  ff #  and   #  enforce a
condition of the following form
ff

ff fi 

 
 
 ffi fi ff fi fi  
 (7.9)
where  encode the acceptable level of error discrepancy as function of the differ-
ence in fragment length. Typically, the maximum difference in error should vary
from  
 or  
 to maybe 
 or   
 .
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We can also state a limit on the error contribution for a given offset   from the
expected fragment length for a particular % -gene  :

 
  	

 

ff 
 	
 (7.10)
where   represents a maximum acceptable total error over the   restriction groups
for % -gene  .
Generally, the above conditions do not uniquely determine the assignment vari-
ables and it is an optimization problem to compute the best assignment for a par-
ticular experiment and some given cost function. Part of such a cost function
could be a weighted sum of the above errors:
Definition 7.6 Let the MATCHING PENALTY for a given matching of a particular
% -gene  be defined by the following expression:
   
 

 
  	


ff  

ff








	





	


ff   

ff fi 


 
    
where    are function parameters encoding the relative weight we give to each
individual match error for a given % -gene  and restriction group  ,     are con-
stant parameters encoding the relative weight given to error discrepancies for
each pair      of restriction groups and   is a constant parameter encoding
the relative penalty, and   is a constant parameter encoding the relative penalty
given to offsets in polyadenylation site for % -gene  .
The  ff can in an assumed underlying essentially linear optimizer still depend both
on the sign and the size of   ff fi   . We here assume such a dependence, and also
a dependence on the expected fragment length in each enzyme group. Similarly,
the  ff  should probably depend on the size and difference in expected fragment
lengths for the gene  in enzyme groups  and  . The   should probably depend
on the confidence we put the polyadenylation site used to compute the expected
fragment lengths for gene  . We note that the matching penalty (Def. 7.6), for all
its complexity, still does not take into account any quantitative measures at all. In
principle we can make an assignment of  to all    variables that give a penalty of

and fulfill all necessary condition mentioned so far. In order to really assess an
assignment we need to take into account also the quantitative expression of each
% -gene and the areas of peaks assigned to the % -gene.
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7.4 Quantitative comparison with expression levels
Definition 7.7 Let the quantitative level of expression of the  :th % -gene be repre-
sented by a variable
 
 in the same unit as that used to express the area

 of each
peak ff  5.
We make the following observations:
1. The sum of contributions to a particular observed peak may not (up to the
some error) exceed the area of the peak itself
2. The opposite is not true since there may be unknown % -genes contributing
to any particular observed peak
3. The matching procedure should however aim to minimize the sum of such
“unexplained” peak areas
Based on the first observation we can define for each peak in an experiment a
necessary condition:
Condition 7.8 We enforce for each observed peak ff  and any given matching the
following condition on the expression variables:
'
 +(
ffi
 
   




	
	


 



ffi


 +(



(7.11)
where   is a parameter representing a maximum acceptable AREA UNDERESTI-
MATION of the area of the peak ( . We let   depend on the position   of peak
ff
 .
A value of 2 for  allows a factor two of area underestimation of a peak in the
experiment, which appears to be a realistic first estimation. This formulation does
not take care of systematic errors such as those discussed above in Sect. 3, which
we assumed have been corrected for. To be able to penalize both area underes-
timation and unexplained area of observed peaks we will define first an absolute
error and then based on this quantitative penalties for a given matching.
Definition 7.9 Let the ABSOLUTE QUANTITATIVE ERROR    for each observed
peak ( and any given matching be defined by





 +(

fi
  




	
	


 



(7.12)
5The  ( variables correspond exactly to the  variables of Sect. 5
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Note that if there is no % -gene assigned to a particular peak the absolute quantita-
tive expression error will be equal to the area of the peak. Note also that in the
case of area underestimation the absolute error will be negative.
Definition 7.10 Let the area underestimation penalty

   for a particular peak
ff
 be defined by the following expression

  




   


 


 %
	

	
 
 (7.13)
Definition 7.11 Let the area underestimation penalty     for a particular peak
ff
 be defined by the following expression
   
 






  



  

ffi%
	
 	
 
 (7.14)
We will now define a cost function to replace the one suggested in Def. 7.6 above
with one based on the quantitative expression error as follows:
Definition 7.12 Let the TOTAL PENALTY for a given matching and a given as-
signment of the expression variables
 
 be defined by the following expression:

   
   




	


  




	

#   (7.15)
where  and  are some suitable weights expressing the relative contribution to
the penalty from area underestimation and unexplained area of observed peaks
respectively
Assign values to
 
 and discrete values to  ff and   for all     ffi  and
   
ffi
  so as to minimize the expression in Def. 7.12 subject to the conditions
on matchings expressed in equations (7.2), (7.3), (7.4) (7.5) and (7.6), the bounds
on matching errors expressed in equations (7.8), (7.9) and (7.10), and condition
(7.8) on the area underestimation.
7.5 Final notes on search procedure
For purposes of search we can decompose the problem into independent subprob-
lems as follows.
Definition 7.13 Let for each % -gene  its CANDIDATE PEAKS in each restriction
group be the domain of the variable  ff constrained by the conditions above.
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Definition 7.14 Let furthermore the CANDIDATE % -GENES of a peak ff  be all the
% -genes whose candidate peaks include ff  .
The set of candidate % -genes of the candidate peaks of a particular % -gene can
extended by recursively considering candidate % -genes and peaks.
Definition 7.15 Let the cluster of a particular % -gene be the transitive closure of
the candidate % -genes of its candidate peaks.
The utility of an assignment of all variables associated with a particular % -gene
can be assessed by considering its relative contribution to the the areas of peaks
assigned to it. This could be used to formulate heuristics for search of optimal
assignments.
Definition 7.16 Let the relative contribution of a % -gene  to the peaks it is as-
signed to be defined by the following expression



	


 
    
    ff
# 

 %
	

	
 

(7.16)
8 Local search
Local search is a general designation of heuristics that try to find an optimum of
a nonlinear minimization problem by small local steps. In a way, they generalize
methods of the continuum that try to go down a gradient, viz. the conjugate gradi-
ent method [18], and share the same defect: in general it is difficult to know if one
has found a global minimum, or just a local minimum. In practice one therefore
often restarts the method more than once, and checks a posteriori if the results of
this sampling are consistent with a true minimum been found.
Three examples of often used methods of local search are genetic algorithms,
simulated annealing and taboo search. Details and an implementation of a meta-
algorithm using complete enumeration, taboo search and best/first improvements
on subproblems of different sizes are presented elsewhere [1]. We will here briefly
describe simulated annealing in the present context.
We want to define state variables and state space of the problem. Let out  %  
be the set of links in  " that start at t-gene %  . Associate to each of these links ( a
variable  , equal to  or  . We can refer to this variable as the spin of the link; it
is analogous to the decision variables  fi    in Sect. 6. The state variables are the
link spins. As auxiliary variables, we have the gene expression levels of (5.1).
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A set of link spins is identified with an assignment / according to
'
(

 	% 
 


#"
     


 
 +(  /
  (8.1)
The state space is hence the set of configurations of the link spins that can be
identified with an assignment. The auxiliary gene expression variables must be
non-negative. Following the discussion in Sect. 5 we can assume an a priori prob-
ability of a configuration of the state variables and the auxiliary variables. We now
assume that we can solve for the auxiliary variables 
 
 that maximizes proba-
bility for a given configuration of the spin variables   .
That will then give a probability of a configuration of the spin variables only. In
statistical mechanics, such a probability would be proportional to  
		 


, where

is the energy of the configuration, and  the absolute temperature. Up to the
temperature, the energy can be identified with the target function fl of (5.4). We
introduce the concepts state sum and free energy

 	
  




 
 	
 
fi 

 
 (8.2)
We have, at least in systems with a unique global minimum, that the free energy
at zero temperature is the minimum energy
Min


Lim 


 
 (8.3)
Equations (8.2) and (8.3) form the basis for simulated annealing. The procedure
is as follows:
 start with some value 
 start with some initial configuration  
 generate local changes to    .
 always accept the change if they lower energy
 accept the change with probability   
 if the energy change


is positive
 generate enough changes such that the average free energy at this tempera-
ture has stabilized
 lower temperature and loop
The major problems in implementing a simulated annealing procedure is how to
generate the local moves, so that they cover all of state space, and how to lower
temperature. Both may require trial-and-error experiments [18].
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9 Conclusion
The first and main message is that the invention of Global Genomics naturally
leads to a combinatorial optimization problem. With reasonable choices of the
target function, such that it is finitary and linear, this problem can efficiently be
solved with mixed-integer programming (MIP) techniques. Such techniques have
the great advantage, in an industrial setting, that the limitations of the method are
well understood, and that very good commercial solvers are available. We believe
in fact that these may have much wider applicability in Bioinformatics.
A second message is that, as an alternative to MIP one may also use constraint
programming (CP) techniques. Although we have not checked that on this prob-
lem, CP can in principle handle more complex linear constraint structures than
MIP, and can thus give an advantage in taking some classes of experimental errors
into account. We have in this project performed a feasibility study, and imple-
mented some parts of the CP solver.
The third and final message is that heuristics, local search techniques, can also
be used, and may allow even better modeling of the error sources. In a continua-
tion of this work, a local search solver has been implemented, and compared with
the MIP solver. All three models can, and should, be evaluated against quantita-
tively precise direct measurements of expression levels on a gene-by-gene basis.
At present, such tests are only in the pipeline for the fully operational MIP solver.
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